Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
Dollar change
Percentage change
Index- P/E52.54 EPS (ttm)0.08 Insider Own12.69% Shs Outstand25.35M Perf Week-0.45%
Market Cap114.19M Forward P/E17.12 EPS next Y0.26 Insider Trans0.00% Shs Float22.40M Perf Month-6.12%
Income2.23M PEG- EPS next Q-0.04 Inst Own27.90% Short Float1.63% Perf Quarter19.30%
Sales32.83M P/S3.48 EPS this Y102.78% Inst Trans6.72% Short Ratio5.20 Perf Half Y-0.89%
Book/sh0.66 P/B6.76 EPS next Y2500.00% ROA8.42% Short Interest0.37M Perf Year19.30%
Cash/sh0.86 P/C5.17 EPS next 5Y- ROE15.90% 52W Range2.42 - 5.81 Perf YTD1.60%
Dividend Est.- P/FCF12.33 EPS past 5Y6.23% ROI10.56% 52W High-23.41% Beta1.19
Dividend TTM- Quick Ratio2.51 Sales past 5Y13945.22% Gross Margin72.47% 52W Low83.88% ATR (14)0.22
Dividend Ex-Date- Current Ratio2.61 EPS Y/Y TTM124.86% Oper. Margin5.68% RSI (14)49.06 Volatility3.70% 4.83%
Employees28 Debt/Eq0.35 Sales Y/Y TTM74.19% Profit Margin6.80% Recom1.00 Target Price10.00
Option/ShortYes / Yes LT Debt/Eq0.25 EPS Q/Q81.25% Payout- Rel Volume0.32 Prev Close4.48
Sales Surprise12.29% EPS Surprise80.00% Sales Q/Q118.33% EarningsNov 09 AMC Avg Volume70.44K Price4.45
SMA20-0.96% SMA50-1.42% SMA20010.67% Trades Volume22,704 Change-0.67%
Date Action Analyst Rating Change Price Target Change
Oct-14-21Resumed B. Riley Securities Buy $10
Jan-04-21Reiterated H.C. Wainwright Buy $20 → $15
Sep-20-19Initiated B. Riley FBR Buy $13.50
Jun-10-19Initiated H.C. Wainwright Buy $15
Today 04:01PM
Feb-26-24 08:19AM
Feb-21-24 06:50AM
Feb-02-24 06:50AM
Jan-16-24 07:52AM
11:09AM Loading…
Nov-11-23 11:09AM
Nov-09-23 04:01PM
Oct-30-23 06:50AM
Oct-23-23 05:16AM
Oct-18-23 08:00AM
Oct-04-23 06:50AM
Sep-22-23 12:04PM
Sep-20-23 09:40AM
Sep-12-23 08:50AM
Aug-25-23 11:36AM
06:50AM Loading…
Aug-23-23 06:50AM
Aug-16-23 09:15AM
Aug-13-23 07:52AM
Aug-11-23 12:44PM
Aug-10-23 05:40PM
Aug-08-23 10:50AM
Aug-01-23 04:05PM
Jul-17-23 04:05PM
Jul-15-23 08:40AM
Jun-28-23 06:50AM
May-16-23 11:35AM
May-11-23 05:35PM
May-10-23 06:50AM
04:05PM Loading…
May-03-23 04:05PM
Apr-19-23 11:22AM
Mar-22-23 07:17AM
Mar-18-23 02:03AM
Mar-16-23 05:25PM
Mar-15-23 06:50AM
Mar-07-23 04:05PM
Feb-08-23 12:00PM
Feb-05-23 07:30AM
Jan-31-23 08:00AM
Jan-25-23 10:00AM
Jan-24-23 12:26PM
Jan-23-23 11:01AM
Jan-12-23 10:34AM
Jan-11-23 07:27AM
Nov-23-22 12:37PM
Nov-22-22 12:45PM
Nov-16-22 10:33AM
Nov-10-22 05:45PM
Nov-02-22 04:05PM
Oct-18-22 04:05PM
Sep-27-22 09:05AM
Sep-13-22 09:00AM
Aug-30-22 04:05PM
Aug-11-22 05:35PM
Aug-08-22 10:00AM
Aug-04-22 10:00AM
Aug-02-22 08:00AM
Jul-18-22 08:09AM
Jun-24-22 09:45AM
Jun-13-22 12:28PM
May-13-22 09:08AM
May-12-22 05:15PM
May-10-22 05:45PM
May-05-22 07:25PM
May-03-22 04:02PM
Apr-12-22 10:03AM
Apr-11-22 04:01PM
Mar-16-22 04:02PM
Mar-14-22 07:00AM
Mar-10-22 05:25PM
Mar-08-22 08:00AM
Jan-10-22 05:19AM
Dec-20-21 07:30AM
Nov-26-21 04:43AM
Nov-18-21 02:04PM
Nov-15-21 06:45PM
Nov-08-21 08:29AM
Nov-04-21 03:01PM
Nov-03-21 04:15PM
Oct-28-21 07:30AM
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.